Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
Neuroinflammation: no rose by any other name.
Anesthetic technique in a patient with multiple sclerosis scheduled for laparoscopic nephrectomy for a renal tumor: a case report.
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study.
Comparison of diabetes patients with "demyelinating" diabetic sensorimotor polyneuropathy to those diagnosed with CIDP.
Immunity and inflammation in neurodegenerative diseases.
Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.
The therapeutic use of cannabinoids: Forensic aspects.
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event.
Early detection of thrombin activity in neuroinflammatory disease.
Correction: MRI Correlates of Disability in African-Americans with Multiple Sclerosis.
Is there any relation between chronic cerebrospinal venous insufficiency and multiple sclerosis? - a critical review.
Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
Two cases of multiple sclerosis manifesting after in vitro fertilization procedures.
The association between multiple sclerosis and fracture risk.
Construction and validation of the chronic acquired polyneuropathy patient-reported index, "CAP-PRI:" a disease-specific, health-related quality of life instrument.
Cell Fusion along the Anterior-Posterior Neuroaxis in Mice with Experimental Autoimmune Encephalomyelitis.
Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Clinical outcomes of sacral neuromodulation in patients with neurologic conditions.
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
Tumefactive demyelinating disease with isolated spinal cord involvement.
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
The new era of multiple sclerosis therapy.

Pages